Skip to Content
Merck

ABL1

c-abl oncogene 1, non-receptor tyrosine kinase

Synonyms:
ABL, JTK7, bcr/abl, c-ABL, p150, v-abl
Species:
UniProtKB ID:
Gene ID:
  • Human(25) Summary: The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response. Activity of c-Abl protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. The t(9;22) translocation results in the head-to-tail fusion of the BCR (MIM:151410) and ABL1 genes present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1. The ABL1 gene is expressed as either a 6- or 7-kb mRNA transcript, with alternatively spliced first exons spliced to the common exons 2-11. [provided by RefSeq, Jul 2008]
  • Mouse(11350) c-abl oncogene 1, non-receptor tyrosine kinase
  • Rat(311860) c-abl oncogene 1, non-receptor tyrosine kinase
  • chicken(417181) c-abl oncogene 1, non-receptor tyrosine kinase
  • domestic cat(101087622) c-abl oncogene 1, non-receptor tyrosine kinase
  • Zebrafish(100000720) c-abl oncogene 1, receptor tyrosine kinase
  • cow(540876) c-abl oncogene 1, non-receptor tyrosine kinase
  • naked mole-rat(101724428) c-abl oncogene 1, non-receptor tyrosine kinase
  • Horse(100069715) c-abl oncogene 1, non-receptor tyrosine kinase
  • domestic guinea pig(100720976) c-abl oncogene 1, non-receptor tyrosine kinase
  • dog(491292) c-abl oncogene 1, non-receptor tyrosine kinase
  • sheep(101122941) c-abl oncogene 1, non-receptor tyrosine kinase

Custom & Knockdown Gene Products

  • siRNA

    Shop predesigned siRNA that are designed using the proprietary Rosetta Inpharmatics algorithm.

  • shRNA

    Shop the largest, most validated shRNA collection and build your own clone sets.

  • Custom Gene Products

    We offer a comprehensive portfolio of DNA oligos, RNA oligos and predesigned primers.